{
    "nct_id": "NCT03483675",
    "official_title": "Randomized Feasibility Study of Discontinuation Versus Continuation of Immunosuppressive Therapy (IST) in Patients With Chronic Graft Versus Host Disease (GVHD)",
    "inclusion_criteria": "* Prior first allogeneic stem cell transplant, with any graft source, donor type, and GVHD prophylaxis\n* Patients who are on one systemic immunosuppressive agent for chronic GVHD with a plan to withdraw all systemic IST; hydrocortisone or prednisone continued for treatment of adrenal insufficiency is not considered a systemic IST\n* No evidence of malignancy at the time of enrollment\n* Agree to be evaluated at the transplant center or by local provider every 3 months for 12 months after randomization\n* Agreement to be contacted by phone or e-mail for health status evaluation for up to 3 years\n* Signed, informed consent\nHealthy volunteers allowed",
    "exclusion_criteria": "* Inability to comply with study procedures\n* Pregancy",
    "miscellaneous_criteria": ""
}